Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Clinical trial NCT03435796 · RECRUITING
Trial details
- NCT number
- NCT03435796
- Sponsor
- Celgene
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-19
- Primary completion
- 2036-11-30
- Enrollment
- 1541
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.